Nanjing MeiRui Pharma - Ownership and Business Overview

Life ScienceCompany

Nanjing MeiRui Pharma Ownership

Who owns Nanjing MeiRui Pharma?

Nanjing MeiRui Pharma is owned by GlaxoSmithKline. It was acquired on December 6, 2010.

Nanjing MeiRui Pharma Business Overview

Where is Nanjing MeiRui Pharma headquartered?

Nanjing MeiRui Pharma is headquartered in Shanghai, China.

What sector is Nanjing MeiRui Pharma in?

Nanjing MeiRui Pharma is a life science company.

When was Nanjing MeiRui Pharma founded?

Nanjing MeiRui Pharma was founded in 1996.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

Nanjing MeiRui Pharma Co. Ltd.

Plaza 66 40th floor 1266 Nanjing Road West,
Shanghai, 200040
China,
+86 21 6288 0666

Nanjing MeiRui Pharma Co. Ltd. is a Chinese pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting for overactive bladder syndrome.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Nanjing MeiRui Pharma

Life Science Companies , China Companies